Samer F Hawari, MD | |
104 Selma Dr, Winchester, VA 22601-3834 | |
(540) 678-2800 | |
Not Available |
Full Name | Samer F Hawari |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 28 Years |
Location | 104 Selma Dr, Winchester, Virginia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1245451178 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 0101240707 (Virginia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Valley Health Home Health/west Virginia | Romney, WV | Home health agency |
Winchester Medical Center Hha | Winchester, VA | Home health agency |
Winchester Medical Center | Winchester, VA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Selma Medical Assoc Inc | 5092618611 | 26 |
News Archive
FirstMark, a division of GenWay Biotech that is focused on developing and commercializing noninvasive diagnostic and health monitoring tests for unmet clinical needs, today announced that results from the break-through proof-of-concept clinical study, performed in collaboration with Emory University and MedStar Washington Hospital Center, will be published in the Journal of the American College of Cardiology.
Pharmaceutical Training International, the leading supplier of online and public event-based training courses for the pharma, biotech and medical device sectors, has expanded its game-based learning platform into a fully customisable virtual learning environment.
Using skin cells from young patients who have a severe genetic heart defect, Stanford University School of Medicine scientists have generated beating heart cells that carry the same genetic mutation. The newly created human heart cells - cardiomyocytes - allowed the researchers for the first time to examine and characterize the disorder at the cellular level.
A new anti-inflammatory drug used by patients with type 2 diabetes improved their kidney function during a year-long study involving researchers from UT Southwestern Medical Center.
› Verified 2 days ago
Entity Name | Selma Medical Assoc Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1144325721 PECOS PAC ID: 5092618611 Enrollment ID: O20040130000637 |
News Archive
FirstMark, a division of GenWay Biotech that is focused on developing and commercializing noninvasive diagnostic and health monitoring tests for unmet clinical needs, today announced that results from the break-through proof-of-concept clinical study, performed in collaboration with Emory University and MedStar Washington Hospital Center, will be published in the Journal of the American College of Cardiology.
Pharmaceutical Training International, the leading supplier of online and public event-based training courses for the pharma, biotech and medical device sectors, has expanded its game-based learning platform into a fully customisable virtual learning environment.
Using skin cells from young patients who have a severe genetic heart defect, Stanford University School of Medicine scientists have generated beating heart cells that carry the same genetic mutation. The newly created human heart cells - cardiomyocytes - allowed the researchers for the first time to examine and characterize the disorder at the cellular level.
A new anti-inflammatory drug used by patients with type 2 diabetes improved their kidney function during a year-long study involving researchers from UT Southwestern Medical Center.
› Verified 2 days ago
Entity Name | Hospitalist Medicine Physicians Of Virginia Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1770756991 PECOS PAC ID: 5698842235 Enrollment ID: O20081118000789 |
News Archive
FirstMark, a division of GenWay Biotech that is focused on developing and commercializing noninvasive diagnostic and health monitoring tests for unmet clinical needs, today announced that results from the break-through proof-of-concept clinical study, performed in collaboration with Emory University and MedStar Washington Hospital Center, will be published in the Journal of the American College of Cardiology.
Pharmaceutical Training International, the leading supplier of online and public event-based training courses for the pharma, biotech and medical device sectors, has expanded its game-based learning platform into a fully customisable virtual learning environment.
Using skin cells from young patients who have a severe genetic heart defect, Stanford University School of Medicine scientists have generated beating heart cells that carry the same genetic mutation. The newly created human heart cells - cardiomyocytes - allowed the researchers for the first time to examine and characterize the disorder at the cellular level.
A new anti-inflammatory drug used by patients with type 2 diabetes improved their kidney function during a year-long study involving researchers from UT Southwestern Medical Center.
› Verified 2 days ago
Entity Name | Hospitalist Medicine Physicians Of Fredericksburg, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1447577572 PECOS PAC ID: 7719179407 Enrollment ID: O20101013000902 |
News Archive
FirstMark, a division of GenWay Biotech that is focused on developing and commercializing noninvasive diagnostic and health monitoring tests for unmet clinical needs, today announced that results from the break-through proof-of-concept clinical study, performed in collaboration with Emory University and MedStar Washington Hospital Center, will be published in the Journal of the American College of Cardiology.
Pharmaceutical Training International, the leading supplier of online and public event-based training courses for the pharma, biotech and medical device sectors, has expanded its game-based learning platform into a fully customisable virtual learning environment.
Using skin cells from young patients who have a severe genetic heart defect, Stanford University School of Medicine scientists have generated beating heart cells that carry the same genetic mutation. The newly created human heart cells - cardiomyocytes - allowed the researchers for the first time to examine and characterize the disorder at the cellular level.
A new anti-inflammatory drug used by patients with type 2 diabetes improved their kidney function during a year-long study involving researchers from UT Southwestern Medical Center.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Samer F Hawari, MD 104 Selma Dr, Winchester, VA 22601-3834 Ph: (540) 678-2800 | Samer F Hawari, MD 104 Selma Dr, Winchester, VA 22601-3834 Ph: (540) 678-2800 |
News Archive
FirstMark, a division of GenWay Biotech that is focused on developing and commercializing noninvasive diagnostic and health monitoring tests for unmet clinical needs, today announced that results from the break-through proof-of-concept clinical study, performed in collaboration with Emory University and MedStar Washington Hospital Center, will be published in the Journal of the American College of Cardiology.
Pharmaceutical Training International, the leading supplier of online and public event-based training courses for the pharma, biotech and medical device sectors, has expanded its game-based learning platform into a fully customisable virtual learning environment.
Using skin cells from young patients who have a severe genetic heart defect, Stanford University School of Medicine scientists have generated beating heart cells that carry the same genetic mutation. The newly created human heart cells - cardiomyocytes - allowed the researchers for the first time to examine and characterize the disorder at the cellular level.
A new anti-inflammatory drug used by patients with type 2 diabetes improved their kidney function during a year-long study involving researchers from UT Southwestern Medical Center.
› Verified 2 days ago
Barbara Anne Harris Feshami, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 170 Prosperity Dr, Winchester, VA 22602 Phone: 540-869-0600 | |
Katelyn Nicewander, PA-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 607 E Jubal Early Dr, Winchester, VA 22601 Phone: 540-536-2232 | |
Mrs. Angela Lynn Titus, FNP-BC Family Medicine Medicare: Medicare Enrolled Practice Location: 172 Linden Dr Ste 107, Winchester, VA 22601 Phone: 540-678-0767 Fax: 540-678-0769 | |
Dr. Arthur Sterling Ticknor, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 160 Merchant St Ste 100, Winchester, VA 22603 Phone: 540-536-5560 Fax: 540-536-5561 | |
Brendan Michael Flynn, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 333 W Cork St Unit 405, Winchester, VA 22601 Phone: 540-313-9200 | |
Dr. Sean Sutphen, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 607 E Jubal Early Dr, Winchester, VA 22601 Phone: 540-536-2232 Fax: 540-536-2206 | |
Sam Waltos, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 104 Selma Dr, Winchester, VA 22601 Phone: 540-678-2800 Fax: 540-667-0652 |